Clinical Research Directory
Browse clinical research sites, groups, and studies.
Nutrition Impact on PRGF Treatment for Tendinopathy
Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Summary
Given the close correlation reported in the literature between onset and progression of tendon pathology in subjects affected by the alteration of metabolic disorders such as obesity, diabetes mellitus and lipidic metabolic alterations, with the present study the association between the nutritional state, metabolic profile and clinical outcome of patients following treatment with blood-derived orthobiological for shoulder tendinopathies will be evaluated. The primary aim of this study is to identify the proportion of tendinopatic patients responsive and non-responsive to treatment with "Platelet rich growth factors" PRGF at six months follow up and the correlation with their nutritional status.
Official title: Nutrition as a Risk Factor and Predictor of Treatment Outcome With Plasma Rich Growth Factors for Shoulder Tendinopathy
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
OBSERVATIONAL
Enrollment
52
Start Date
2024-02-15
Completion Date
2027-02-15
Last Updated
2024-08-05
Healthy Volunteers
Yes
Interventions
Platelet rich growth factor injection (autologous product)
All patients will undergo two PRGF injections, one at recruitment and one 14 days after the first injection. The injection site will be the shoulder with tendinopathy.
Locations (1)
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Milan, Italy